Extracellular Matrix Remodeling in Takayasu's Arteritis: Role of Matrix Metalloproteinases and Adventitial Inflammation

Archives of Medical Research

Volumn 43, Issue 5, 2012, Pages 406-410

  Mahajan, Nitin ^a,b   Dhawan, Veena ^a   Mahmood, Safrun ^a   Malik, Sonal ^a   Jain, Sanjay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adventitia; Fibroblasts; Matrix metalloproteinase; T cell; Takayasu's arteritis

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MEMBRANE ANTIGEN; PHYTOHEMAGGLUTININ; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADVENTITIA; ANGIOPLASTY; AORTA ARCH SYNDROME; ARTICLE; CELL ACTIVATION; CELL FRACTIONATION; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FIBROSARCOMA; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SARCOMA CELL; T CELL LYMPHOMA; T LYMPHOCYTE;

ADOLESCENT; ADULT; ADVENTITIA; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RNA, MESSENGER; TAKAYASU ARTERITIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84866161186     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.07.007     Document Type: Article

References (26)

1. Seko Y. Takayasu arteritis: insights into immunopathology. Jpn Heart J 2000, 41:15-26.
2. Parakh R., Yadav A. Takayasu's arteritis: an Indian perspective. Eur J Vasc Endovasc Surg 2007, 33:578-582.
3. Wilcox J.N., Scott N.A. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996, 54(suppl):S21-S35.
4. Hu C.L., Xiang J.Z., Hu F.F., et al. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque. Med Hypotheses 2007, 68:1262-1264.
5. Xu F., Ji J., Li L., et al. Activation of adventitial fibroblasts contributes to the early development of atherosclerosis: a novel hypothesis that complements the response-to-injury hypothesis and the inflammation hypothesis. Med Hypotheses 2007, 69:908-912.
6. Newby A.C. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2008, 28:2108-2114.
7. Lacraz S., Isler P., Vey E., et al. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 1994, 269:22027-22033.
8. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
9. Libby P., Okamoto Y., Rocha V.Z., et al. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010, 74:213-220.
10. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38.
11. Dhawan V., Mahajan N., Jain S. Role of C-C chemokines in Takayasu's arteritis disease. Int J Cardiol 2006, 112:105-111.
12. Mahajan N., Dhawan V., Malik S., et al. Serum levels of soluble receptor for advanced glycation end products (sRAGE) in Takayasu's arteritis. Int J Cardiol 2010, 145:589-591.
13. Mahajan N., Dhawan V., Malik S., et al. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease. Int J Cardiol 2010, 145:286-288.
14. Mahajan N., Malik N., Bahl A., et al. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis 2009, 207:597-602.
15. Dhar J., Ganguly N.K., Kumari S., et al. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis. Jpn Heart J 1995, 36:341-348.
16. Aderem A.A., Keum M.M., Pure E., et al. Bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the myristoylation of specific macrophage proteins. Proc Natl Acad Sci USA 1986, 83:5817-5821.
17. Mahajan N., Dhawan V. Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells. Mol Cell Biochem 2010, 338:77-86.
18. Newby A.C. Matrix metalloproteinase inhibition therapy for vascular diseases. Vasc Pharmacol 2012, 56:232-244.
19. Sueyoshi E., Sakamoto I., Hayashi K. Aortic aneurysms in patients with Takayasu's arteritis: CT evaluation. Am J Roentgenol 2000, 175:1727-1733.
20. Chauhan S.K., Tripathy N.K., Nityanand S. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthr Rheumat 2006, 54:2326-2333.
21. Mahajan N., Dhawan V. Potential biomarkers for disease activity in Takayasu's arteritis. Int J Cardiol 2012, 158:331.
22. Rey F.E., Pagano P.J. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 2002, 22:1962-1971.
23. Matsuyama A., Sakai N., Ishigami M., et al. Minocycline for the treatment of Takayasu arteritis. Ann Intern Med 2005, 143:394-395.
24. Matsuyama A., Sakai N., Ishigami M., et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003, 108:1469-1473.
25. Huet E., Vallee B., Szul D., et al. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 2008, 22:1144-1154.
26. Nie R., Xie S., Du B., et al. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction. Arch Med Res 2009, 40:605-611.